NSB — Neuroscientific Biopharmaceuticals Share News
0.000.00%
Last trade - 00:00- AU$21.82m
- AU$17.28m
- AU$0.63m
Australia Stock Exchange release from NEUROSCIENTIFIC : NSB partners with Linear Research for Phase I Clinical Study
Australia Stock Exchange release from NEUROSCIENTIFIC : PRE_NR Ends: 08:29:34
Australia Stock Exchange release from NEUROSCIENTIFIC : Proposed issue of securities - NSB
Brief: Neuroscientific Biopharmaceuticals Says Paul Rennie Appointed Non-Executive Chairman
Australia Stock Exchange release from NEUROSCIENTIFIC : Appointment of Non-executive Chairman
Australia Stock Exchange release from NEUROSCIENTIFIC : R&D Tax Rebate Received
Australia Stock Exchange release from NEUROSCIENTIFIC : PRE_NR Ends: 11:41:59
Australia Stock Exchange release from NEUROSCIENTIFIC : Appendix 3G
Australia Stock Exchange release from NEUROSCIENTIFIC : Final Director's Interest Notice
Brief: Neuroscientific Biopharmaceuticals Accepts Resignation Of Non-Executive Chairman Brian Leedman
Australia Stock Exchange release from NEUROSCIENTIFIC : Director Appointment/Resignation
Australia Stock Exchange release from NEUROSCIENTIFIC : Change of Director's Interest Notice
Australia Stock Exchange release from NEUROSCIENTIFIC : Change of Director's Interest Notice
Australia Stock Exchange release from NEUROSCIENTIFIC : Update on Pivotal Ocular Safety Studies
Australia Stock Exchange release from NEUROSCIENTIFIC : PRE_NR Ends: 08:32:14
Australia Stock Exchange release from NEUROSCIENTIFIC : PRE_NR Ends: 09:44:37
Australia Stock Exchange release from NEUROSCIENTIFIC : Appendix 4C - quarterly
Australia Stock Exchange release from NEUROSCIENTIFIC : Manufacturing Update
Australia Stock Exchange release from NEUROSCIENTIFIC : PRE_NR Ends: 08:30:48